advertisement

Oculus

3.8 Pharmacology (195)

Showing records 1 to 25

Display all abstracts in classification 3.8 Pharmacology

Search within classification 3.8 Pharmacology
81042 Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure
Fan Y
Investigative Ophthalmology and Visual Science 2019; 60: 2072-2082
81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Wu J
Scientific reports 2019; 9: 9057
81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Li X
International Journal of Molecular Medicine 2019; 44: 503-512
81044 Neovascular glaucoma regulation by arylsulfonyl indoline-benzamide (ASIB) through targeting NF-kB signalling pathway
Lei X
3 Biotech 2019; 9: 211
80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
He JN
Molecular Neurobiology 2019; 56: 6586-6593
80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
Chen Q
Journal of Cellular Biochemistry 2019; 120: 13133-13140
81414 Quercetin Enhances Inhibitory Synaptic Inputs and Reduces Excitatory Synaptic Inputs to OFF- and ON-Type Retinal Ganglion Cells in a Chronic Glaucoma Rat Model
Zhou X
Frontiers in neuroscience 2019; 13: 672
81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Coman IC
Romanian journal of ophthalmology 2019; 63: 135-141
80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Jia Y
Molecular medicine reports 2019; 19: 4863-4871
80824 Targeting P2X7 receptors as a means for treating retinal disease
Fletcher EL
Drug Discovery Today 2019; 24: 1598-1605
80869 PACAP Attenuates Optic Nerve Crush-Induced Retinal Ganglion Cell Apoptosis Via Activation of the CREB-Bcl-2 Pathway
Ye D
Journal of Molecular Neuroscience 2019; 68: 475-484
81289 Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
Okamoto M
British Journal of Ophthalmology 2019; 0:
81212 Pressure-dependent modulation of inward-rectifying K channels: implications for cation homeostasis and K dynamics in glaucoma
Fischer RA
American Journal of Physiology and Cell Physiology 2019; 317: C375-C389
81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Wen J
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
80532 Mitochondrial Uncoupling Protein 2 Knock-out Promotes Mitophagy to Decrease Retinal Ganglion Cell Death in a Mouse Model of Glaucoma
Hass DT
Journal of Neuroscience 2019; 39: 3582-3596
80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
He JN
Molecular Neurobiology 2019; 56: 6586-6593
80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Laspas P
Scientific reports 2019; 9: 5222
81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Trzeciecka A
Data in brief 2019; 24: 103950
80984 Effects of Resveratrol on Inflammatory Biomarkers in Glaucomatous Human Trabecular Meshwork Cells
Avotri S
Nutrients 2019; 11:
81272 1α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathway
Lv Y
Biochemical and Biophysical Research Communications 2019; 516: 75-81
80603 GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure
Itakura T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 203-215
81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Schlüter A
Molecular Neurobiology 2019; 0:
80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Wu X
Acta biochimica et biophysica Sinica 2019; 51: 411-421
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698
81225 Nitric oxide: a drug target for glaucoma revisited
Garhöfer G
Drug Discovery Today 2019; 24: 1614-1620

Issue 20-3

Select Issue


advertisement

WGW-2021